INVESTIGATION OF THE ACTION OF HISTONE DEACETYLASE INHIBITORS IN EX VIVO AND IN VITRO MODELS OF INFLAMMATORY BOWEL DISEASE

被引:0
|
作者
Edwards, A. J. P. [1 ]
Gwiggner, M. [1 ]
Claridge, A. G. [1 ]
Morgan-Walsh, R. J. [1 ]
Hayden, A. L. [2 ]
Bateman, A. [3 ]
Cummings, J. R. F. [4 ]
Packham, G. K. [2 ]
Pender, S. L. F. [1 ]
机构
[1] Univ Southampton, Fac Med, Dept Clin & Expt Sci, Southampton SO9 5NH, Hants, England
[2] Univ Southampton, Dept Canc Sci, Southampton, Hants, England
[3] Univ Hosp Southampton NHS Fdn Trust, Dept Pathol, Southampton, Hants, England
[4] Univ Hosp Southampton NHS Fdn, Dept Gastroenterol, Southampton, Hants, England
关键词
D O I
10.1136/gutjnl-2012-302514a.161
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A69 / A69
页数:1
相关论文
共 50 条
  • [31] Histone deacetylase inhibitors as a potential new treatment for psoriatic disease and other inflammatory conditions
    Nazri, Jehan Mohammad
    Oikonomopoulou, Katerina
    de Araujo, Elvin D.
    Kraskouskaya, Dziyana
    Gunning, Patrick T.
    Chandran, Vinod
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (04) : 300 - 320
  • [32] Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
    Sanaei, Masumeh
    Kavoosi, Fraidoon
    ADVANCED BIOMEDICAL RESEARCH, 2019, 8 (01): : 63
  • [33] Collagenase and histone deacetylase inhibitors: An investigation of zinc metalloenzyme inhibitors.
    Knudsen, GA
    Seeley, SK
    Zand, AR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U27 - U28
  • [34] Quinazolines as novel anti-inflammatory histone deacetylase inhibitors
    Lin, Zhigang
    Murray, Pamela M.
    Ding, Yaoyao
    Denny, William A.
    Ferguson, Lynnette R.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 690 (1-2) : 81 - 88
  • [35] Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?
    Blanchard, F
    Chipoy, C
    DRUG DISCOVERY TODAY, 2005, 10 (03) : 197 - 204
  • [36] Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases
    Cantley, Melissa D.
    Bartold, Peter M.
    Fairlie, David P.
    Rainsford, K. D.
    Haynes, David R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2012, 64 (06) : 763 - 774
  • [37] Histone deacetylase inhibitors as novel anti-inflammatory agents
    Adcock, Ian M.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (11) : 966 - 973
  • [38] Histone deacetylase inhibitors:: mechanism of action and therapeutic use in cancer
    Martinez-Iglesias, Olaia
    Ruiz-Llorente, Lidia
    Sanchez-Martinez, Ruth
    Garcia, Laura
    Zambrano, Alberto
    Aranda, Ana
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (07): : 395 - 398
  • [39] Enhancing the anti-angiogenic action of histone deacetylase inhibitors
    Kuljaca, Selena
    Liu, Tao
    El Tee, Andrew
    Haber, Michelle
    Norris, Murray D.
    Dwarte, Tanya
    Marshall, Glenn M.
    MOLECULAR CANCER, 2007, 6 (1)
  • [40] Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer
    Olaia Martínez-Iglesias
    Lidia Ruiz-Llorente
    Ruth Sánchez-Martínez
    Laura García
    Alberto Zambrano
    Ana Aranda
    Clinical and Translational Oncology, 2008, 10 : 395 - 398